Garden Stage Limited Secures Nasdaq Compliance Amid $4.2M Offering

Introduction

Garden Stage Limited (NASDAQ: GSIW) is a holding company incorporated in the Cayman Islands. Through its subsidiaries and a variable interest entity, it provides securities underwriting, brokerage, investment advisory, and asset management services in Hong Kong. The company's American Depositary Shares began trading on the Nasdaq Capital Market on December 1, 2023.

Corporate Structure

Garden Stage operates primarily through two regulated Hong Kong subsidiaries. I Win Securities Limited holds a Type 1 (dealing in securities) license under the Securities and Futures Ordinance. I Win Asset Management Limited is licensed for Type 4 (advising on securities) and Type 9 (asset management) activities. As of July 25, 2025, there are 35.63 million ordinary shares outstanding.

Securities Trading by Shubham Dhage

Developments and News

• On March 1, 2024, Garden Stage Limited rang the Nasdaq closing bell at the Nasdaq MarketSite in Times Square.
• The company received a Nasdaq deficiency notice on December 24, 2024, after trading below $1.00 for 30 consecutive business days.
• Garden Stage regained compliance with Nasdaq Listing Rule 5550(a)(2) on June 24, 2025, by maintaining a closing bid price at or above $1.00 for ten consecutive business days.
• In June 2025, the company announced a registered direct offering to raise approximately $4.2 million through the sale of 38,406,345 ordinary shares at $0.11 per share, including pre-funded warrants. The offering is expected to close on July 25, 2025, with Univest Securities, LLC acting as placement agent.
• On July 2, 2025, Mr. Sheng Tang resigned from the board for personal reasons. The board is in the process of seeking a replacement director.

Financial and Strategic Analysis

On July 25, 2025, Garden Stage's share price closed at $0.1442, reflecting a 32.29% increase on a volume of 11,762,569 shares. With 35.63 million shares outstanding, the market capitalization is approximately $5.1 million. For the trailing twelve months, the company reported revenue of $1.36 million, a negative EBITDA of $7.08 million, and a net margin of -522.14%. The company cited a negative EPS of $0.34 and a P/E ratio of 0.32. Its return on equity was reported at 159.87%, indicating high leverage relative to its equity.

Strategically, Garden Stage has developed its product offerings through cooperation agreements. Its securities arm is in discussions with derivative trading units at CICC and JPMorgan Chase Bank to facilitate the distribution of participation notes and options linked to A-share performance. The asset management subsidiary has entered into strategic cooperation with Indicator Global Inc. and ZZC International to enhance client connectivity and explore potential joint ventures.

Market Position and Industry Context

Garden Stage operates within Hong Kong’s capital markets, regulated by the Securities and Futures Commission. The firm competes with established brokerage and asset management companies in a market with stringent regulatory requirements and changing investor sentiment. As of July 25, 2025, the ADS price has declined 83.63% from its 52-week high of $12.30 achieved on September 12, 2024, to a low of $0.10 recorded on July 24, 2025. The average daily trading volume over the past ten trading days was approximately 41.34 million shares, indicating continued trading activity despite price fluctuations.

TL;DR

Garden Stage Limited is conducting a registered direct offering at $0.11 per share, expected to close on July 25, 2025, with aims to raise $4.2 million. The company regained Nasdaq compliance on June 24, 2025, following a deficiency notice on December 24, 2024. A board vacancy arose on July 2, 2025, and the firm is expanding its distribution partnerships for structured products and asset management services.